HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding the U.S. Food and Drug Administration (FDA) for releasing new data to help generic drug competitors:
Click here for the full statement.
Related Posts
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
April 2, 2019
Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA E&C Letter on Improving Competition in the Generic Marketplace
April 1, 2019
Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...